An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

Item

http://www.wikidata.org/entity/Q33979114

Q33979114

about

Megestrol acetate for treatment of anorexia-cachexia syndrome Megestrol acetate for treatment of anorexia-cachexia syndrome Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia Gaps in nutritional research among older adults with cancer Cancer cachexia: impact, mechanisms and emerging treatments Neurobiology of inflammation-associated anorexia.Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.Clinical anticachexia treatments.Novel treatments for cancer cachexia.Computational modeling of cancer cachexia.Treatment of cachexia in oncology A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project.A structured exercise program for patients with advanced non-small cell lung cancer Nutrition modulation of cachexia/proteolysis.Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.A novel role for CD4+ T cells in the control of cachexia Cancer cachexia: mechanisms and clinical implications.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatment Pathophysiology and treatment of inflammatory anorexia in chronic disease.Nutritional interventions for cancer-induced cachexia Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia Skeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium.Cancer symptom control trials: how may we advance this field?n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention.Omega-3 fatty acid supplements for cancer-associated weight loss.Treatment of unintentional weight loss in patients with cancer.Multifocal angiostatic therapy: an update.Guidelines for the use of orexigenic drugs in long-term care.Toward a core nutraceutical program for cancer management.Nutrition in cachexia: from bench to bedside.Pharmacological options for advanced cancer patients with loss of appetite and weight.Megestrol acetate in cachexia and anorexia Multi-targeted therapy of cancer by omega-3 fatty acids.Fatigue in palliative care patients -- an EAPC approach.Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice

P2860

Q24198954-B249DA0F-D88F-4964-BB72-92957E050E80 Q24244142-B0BFD6E1-E4AA-4601-889F-A0626C816A20 Q24246397-96883B18-B17F-4F5E-A282-EC8740D6E388 Q26778695-68489F81-DB1A-4400-AE19-1E35387A3C00 Q26827510-7E82BCE1-083B-4ED6-8689-2679E86C4ED0 Q28067552-C6C86D66-84BA-425D-B71C-1C0C71FE5BD4 Q28384479-DF16E5DF-3A99-462C-82CE-E67973F8B4A3 Q33806456-A8FF366E-E427-454D-9352-8990098900C7 Q33991186-3C201017-5B54-4DA6-87CF-89AAFD6BAAAC Q33994400-B13C52B2-73E2-4FBD-BA13-E6E27323AD6C Q34005616-89FB6DCB-514A-42AB-B075-38F068D8EEA7 Q34011017-21D95F78-05A2-4821-8DE5-82FAC0F0F516 Q34158188-BE7B2F31-F5C6-4C4D-9B41-F25F5A1145CE Q34210506-0882AD0E-C4A2-4AE1-A452-EC2C621042CE Q34284843-08F33765-F1E9-4294-A1F1-40F233D22C5A Q34565917-728ADA02-1BEA-4201-A373-D25F160D9E0D Q34583647-5A9E681C-3C1D-47FB-8E2B-070363322BD3 Q34597316-9C61A012-4023-4D62-A407-724C69024177 Q34631019-EBDAC4CF-FC9F-4AF0-8647-483C8DF79EDB Q34660312-15851ACE-C8C1-41A7-A80C-C449DBFF4300 Q34669440-17753326-48D9-40FE-B1AE-8917DF333594 Q34697279-2D0E38B6-E905-420A-88EB-1511A63BFCA7 Q35019743-CFBBB2AE-50C5-4C00-8E72-41585C0291D0 Q35122201-BDD5A357-07CC-48AA-BB3F-E97F874F9E5D Q35583902-AD7F48E4-24AA-418F-ACB7-E54400294F8F Q35781409-14BC1E0E-89D8-4F4C-9582-4899D855DEF2 Q35855357-F0B9F029-1A6E-43F9-9F36-B54A95731D0E Q36131716-EB57C64D-79CD-4D6E-A58B-F9C20A6DBD78 Q36278403-9653E9ED-D8C0-46E4-B77C-CA005DDB87D6 Q36278408-FD2A9737-BCC8-4B6A-8203-ACA8FC46F3E7 Q36311166-8FBB04A7-D7C3-4FBE-B7BB-27CE6BB4D155 Q36378763-E46BAA10-69A6-446B-8EC5-0A6200B90525 Q36473648-CF4A4502-293A-4E22-A202-378ACE45C3A7 Q36679436-BE7E7964-334B-4618-BDAD-6EFEF1AC59BA Q36828134-2334BBB6-D806-4101-B9AD-130F0527AA1E Q36920325-EF5EA8BB-6720-4187-A93D-9CD54A00076A Q36947010-E2EBC4AB-BD40-43DB-B299-1C0A93E7170E Q37063833-96D08B05-6DE3-42F6-94F1-B49F77E08E2A Q37103603-B76A13AB-36E2-461F-B0BC-B7D7D8D68C7D Q37123496-CF2695E6-CB63-4E62-B779-0C806926A96D

P2860

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

Item

http://www.wikidata.org/entity/Q33979114

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu